CDSCO panel approves Oxford COVID-19 vaccine for emergency use
Team Udayavani, Jan 1, 2021, 5:47 PM IST
New Delhi: An expert panel on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) has approved the emergency use authorisation for the Oxford COVID-19 vaccine Covishield, being manufactured by Serum Institute of India.
The Pune-based Serum Institute of India (SII), the world’s largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Wednesday had approved the COVID-19 vaccine developed by scientists at Oxford University and produced by AstraZeneca for human use.
The Subject Expert Committee (SEC) on COVID-19 of the CDSCO, which had earlier sought additional safety and immunogenicity data from SII, deliberated on its application seeking emergency use authorisation (EUA) for the shots on Wednesday, and met again on Friday to review the matter.
More details to be added
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
IPL 2021: RCB retains 12 players from IPL 2020
Eatery at Pune launches a contest, eat 4kg thali and win Royal Enfield Bullet
Ramalinga Reddy, Dhruva Narayana selected as KPCC Working Presidents
Related Articles More
COVID-19 vaccines sent by India reach Bhutan and Maldives
Former Arunachal Pradesh governor Mata Prasad passes away
Unsold ticket makes Kerala lottery seller crorepati
Sasikala shifted to hospital after complaining of fever and breathlessness
Vandalisation of TN name boards on Karna border: Panel formed to survey location of such markings